研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

肺癌的传统中医治疗方法患者偏好与共享决策:离散选择实验研究。

Patient preferences and shared decision making for the traditional Chinese medicine treatment of lung cancer: A discrete choice experiment study.

发表日期:2023 Sep
作者: Yue Teng, Yan Wei, Yingyao Chen, Juntao Yan, Shimeng Liu, Fuming Li, Shiyi Bao, Yanfeng Ren, Liu Liu, Yi Yang
来源: Integrative Medicine Research

摘要:

在肺癌的综合疗法中,传统中医药(TCM)将患者偏好融入决策过程中广泛应用。本研究旨在评估上海住院中医法治疗肺癌的患者偏好和共享决策(SDM)模式,为中医药治疗肺癌的临床决策过程提供基础。本研究采用离散选择实验(DCE)调查和共享决策问卷-患者版(SDM-Q-9)调查,对上海九家三级医院的患者(n = 347)进行。在TCM治疗肺癌的最相关属性和适当水平的基础上开发了DCE。使用混合逻辑模型对患者的实证数据进行分析。此外,进行了亚组分析。共有347名受访者完成了问卷调查。所有属性的系数对患者的偏好都具有统计学意义。患者对提高疾病控制率、缓解恶心呕吐、降低副作用风险显示出强烈的偏好,并关注每月的个人支付费用。亚组分析表明,SDM-Q-9评分较低和对医疗服务满意的患者更加重视提高疾病控制率。此外,大多数患者(90.20%)自称在决策过程中使用共享决策时非常愿意。在上海,患者主要偏好SDM,并认为疾病控制率是中医药治疗肺癌最基本的属性。研究结果强调了考虑患者偏好和促进共享决策的重要性。© 2023年韩国东方医学研究所。由Elsevier B.V.出版。
Traditional Chinese Medicine (TCM), integrating patient preferences into decision-making process, has been widely used in the multimodality therapy of lung cancer. This study aimed to estimate patient preferences for treatment and shared decision-making (SDM) modes concerning inpatient TCM treatment of lung cancer in Shanghai in order to provide a basis for clinical decision-making process on TCM therapy for lung cancer.This study was conducted among patients (n = 347) from nine tertiary hospitals in Shanghai by discrete-choice experiment (DCE) survey and Shared Decision-Making Questionnaire-patient version (SDM-Q-9) survey. The DCE was developed with the inclusion of the most relevant attributes at appropriate levels for the TCM treatment of lung cancer. The empirical data analyses of patients were performed using mixed logit models. Additionally, subgroup analysis was conducted.In total, 347 respondents completed the questionnaire. All attributes' coefficients were statistically significant for patients' preferences. Patients showed strong preferences for increasing disease control rate, relieving nausea and vomiting, reducing the risk of side effects, and were concerned about monthly out-of-pocket costs. Subgroup analysis indicated that patients with a lower SDM-Q-9 score and those who were satisfied with medical services emphasized more importance of higher disease control rate. Furthermore, most of the patients (90.20%) self-reported a high willingness to use SDM during the decision-making process.In Shanghai, patients mainly preferred SDM and considered disease control rate as the most essential attribute in the TCM treatment of lung cancer. The study findings could underscore the importance of considering patients' preferences and promote SDM.© 2023 Korea Institute of Oriental Medicine. Published by Elsevier B.V.